EP4347847A1 - Flexible Expression Vector Systems for Vaccines and Immunotherapeutics
Summary
The European Patent Office granted patent EP4347847A1 to The University of British Columbia and The James Hutton Institute. The patent covers flexible expression vector systems and their applications in vaccines and immunotherapeutics, with inventors Jefferies and Ribeca. The patent is designated across 31 European member states.
What changed
The European Patent Office granted patent EP4347847A1 for flexible expression vector systems and their applications in vaccines and immunotherapeutics. The patent covers IPC classifications including C12N 15/85 (vectors), A61K 39/12 (vaccines), and A61K 48/00 (gene therapy), with designated states covering 31 European countries including DE, FR, GB, IT, NL, ES, PL, SE, and others.
Affected parties including pharmaceutical companies, biotech developers, and research institutions should conduct IP landscape reviews to assess freedom-to-operate for vector-based vaccine and immunotherapeutic development in Europe. Patent holders may explore licensing opportunities for the technology.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FLEXIBLE EXPRESSION VECTOR SYSTEMS AND APPLICATION OF SAME TO VACCINES AND IMMUNOTHERAPEUTICS
Publication EP4347847A1 Kind: A1 Apr 08, 2026
Applicants
THE UNIVERSITY OF BRITISH COLUMBIA, The James Hutton Institute
Inventors
JEFFERIES, Wilfred A., RIBECA, Paolo
IPC Classifications
C12N 15/85 20060101AFI20250407BHEP A61K 31/713 20060101ALI20250407BHEP A61K 31/7088 20060101ALI20250407BHEP A61K 39/12 20060101ALI20250407BHEP A61K 48/00 20060101ALI20250407BHEP A61K 49/00 20060101ALI20250407BHEP A61P 31/00 20060101ALI20250407BHEP A61P 31/12 20060101ALI20250407BHEP A61P 37/04 20060101ALI20250407BHEP C07K 14/08 20060101ALI20250407BHEP C07K 14/18 20060101ALI20250407BHEP C07K 14/19 20060101ALI20250407BHEP C07K 14/165 20060101ALI20250407BHEP C12N 15/40 20060101ALI20250407BHEP C12N 15/50 20060101ALI20250407BHEP C12N 15/63 20060101ALI20250407BHEP C12N 15/113 20100101ALI20250407BHEP A61K 39/00 20060101ALI20250407BHEP A61K 31/7105 20060101ALI20250407BHEP A61P 31/14 20060101ALI20250407BHEP C12N 15/86 20060101ALI20250407BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.